Russell J. Cox
2017 - Jazz Pharmaceuticals
In 2017, Russell J. Cox earned a total compensation of $3.2M as Former Executive Vice President and COO at Jazz Pharmaceuticals, a 10% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $162,000 |
|---|---|
| Option Awards | $1,060,658 |
| Salary | $587,692 |
| Stock Awards | $1,361,800 |
| Other | $10,722 |
| Total | $3,182,872 |
Cox received $1.4M in stock awards, accounting for 43% of the total pay in 2017.
Cox also received $162K in non-equity incentive plan, $1.1M in option awards, $587.7K in salary and $10.7K in other compensation.
Rankings
In 2017, Russell J. Cox's compensation ranked 3,378th out of 14,666 executives tracked by ExecPay. In other words, Cox earned more than 77.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,378 out of 14,666 | 77th |
Division Manufacturing | 1,159 out of 5,768 | 80th |
Major group Chemicals And Allied Products | 319 out of 2,074 | 85th |
Industry group Drugs | 245 out of 1,730 | 86th |
Industry Pharmaceutical Preparations | 194 out of 1,329 | 85th |
Source: SEC filing on June 15, 2018.
Cox's colleagues
We found five more compensation records of executives who worked with Russell J. Cox at Jazz Pharmaceuticals in 2017.
2017
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2017
Suzanne Hooper
Jazz Pharmaceuticals
Executive Vice President and GC
2017
Matthew Young
Jazz Pharmaceuticals
Chief Financial Officer
2017
Karen Smith
Jazz Pharmaceuticals
Chief Marketing Officer
2017
Michael Miller
Jazz Pharmaceuticals